Monsanto Company (MON) In The Chemicals Spotlight Today

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Monsanto Company ( MON) pushed the Chemicals industry higher today making it today's featured chemicals winner. The industry as a whole closed the day up 0.5%. By the end of trading, Monsanto Company rose $1.45 (1.4%) to $107.10 on average volume. Throughout the day, 2.6 million shares of Monsanto Company exchanged hands as compared to its average daily volume of 2.5 million shares. The stock ranged in a price between $105.32-$107.18 after having opened the day at $105.67 as compared to the previous trading day's close of $105.65. Other companies within the Chemicals industry that increased today were: Amyris ( AMRS), up 5.9%, Ceres ( CERE), up 5.6%, Senomyx ( SNMX), up 5.4%, and NL Industries ( NL), up 4.9%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. Monsanto Company has a market cap of $56.19 billion and is part of the basic materials sector. The company has a P/E ratio of 22.5, above the S&P 500 P/E ratio of 17.7. Shares are up 11.6% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Monsanto Company a buy, two analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Monsanto Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Pure Bioscience ( PURE), down 4.5%, Hawkins ( HWKN), down 4.4%, BioFuel Energy Corporation ( BIOF), down 3.2%, and Pacific Ethanol ( PEIX), down 3.1%, were all laggards within the chemicals industry with CF Industries Holdings ( CF) being today's chemicals industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the chemicals industry could consider Materials Select Sector SPDR ( XLB) while those bearish on the chemicals industry could consider ProShares Short Basic Materials Fd ( SBM).

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

How to Profit From This Lousy Winter Weather

How to Profit From This Lousy Winter Weather

Tesla, Intel, AT&T and Powerball - 5 Things You Must Know

Tesla, Intel, AT&T and Powerball - 5 Things You Must Know

IBM Shares Fall After Warren Buffett Slashes His Stake by a Third

IBM Shares Fall After Warren Buffett Slashes His Stake by a Third

Scientific Study Finds No Link Between Cancer, Monsanto Weedkiller Glyphosate

Scientific Study Finds No Link Between Cancer, Monsanto Weedkiller Glyphosate

Trump's Antitrust Team Sends Mixed Message on M&A

Trump's Antitrust Team Sends Mixed Message on M&A